Compazine Shortage Update: What Patients Need to Know in 2026

Patients who rely on Compazine (prochlorperazine) for severe nausea, vomiting, acute migraines, or other conditions have faced supply challenges at pharmacies across the United States throughout recent years, and those challenges continue into 2026. This article provides a clear, up-to-date picture of what is happening with Compazine availability, which formulations are most affected, and the practical steps you can take today to get your medication.

What Is the Current Status of the Compazine Shortage?

As of 2026, prochlorperazine (the generic form of Compazine) continues to experience supply disruptions. The shortage is not new — it has been a persistent problem driven by structural issues in generic drug manufacturing that have built over the past decade.

The most consistently affected formulation is the injectable form (prochlorperazine edisylate 5 mg/mL), which has been listed on the American Society of Health-System Pharmacists (ASHP) Drug Shortage Database with recurring availability gaps dating back to 2015. Oral tablets and rectal suppositories experience intermittent shortages at the retail pharmacy level.

Which Formulations Are Affected?

Prochlorperazine edisylate injection (5 mg/mL): Most severely and consistently affected. Multiple manufacturers have had production disruptions. Primarily impacts hospitals and emergency settings.

Oral tablets (5 mg and 10 mg): Intermittent shortages at retail pharmacies. Chain pharmacies often face the worst gaps; independent pharmacies may have stock.

Rectal suppositories (25 mg): Intermittently affected. May be available when tablets are not, since they come from different manufacturers.

Why Is Compazine (Prochlorperazine) in Shortage?

The shortage of prochlorperazine reflects a deeper structural crisis in the U.S. generic drug supply. Several compounding factors are at play:

Too few manufacturers: Only a small number of generic manufacturers produce prochlorperazine. A production problem at one facility can cause a nationwide shortage.

Low profit margins: Generic prochlorperazine tablets sell for as little as $0.30 to $1.00 per unit at wholesale. These tiny margins leave manufacturers with little incentive to invest in expanded capacity.

Sterile manufacturing constraints: The injectable form requires specialized sterile manufacturing that is expensive and tightly regulated. FDA inspections and facility remediation efforts limit how quickly supply can be restored.

International supply chain fragility: Raw ingredients (API) are primarily sourced internationally. Disruptions in shipping or regulatory actions against foreign suppliers can halt U.S. production.

How Long Will the Shortage Last?

Unfortunately, there is no reliable timeline for when the shortage will fully resolve. The FDA works with manufacturers on shortage mitigation, but the structural causes are not easily or quickly fixed. New generic suppliers can enter the market, but the FDA approval process for new manufacturers typically takes months to years.

In practical terms, availability tends to fluctuate — meaning your local pharmacy may receive a shipment one week and be out again the next. Staying proactive and using every available search tool is the most effective approach.

6 Steps Patients Can Take Right Now

Search with medfinder. medfinder.com calls pharmacies in your area to check which ones can fill your prescription, then texts you results.

Try independent pharmacies. They source from multiple wholesalers and often have stock when chain pharmacies do not.

Ask about formulation switching. If tablets are out of stock, ask your doctor if suppositories (from a different manufacturer) could work for you, or vice versa.

Check mail-order pharmacies. Amazon Pharmacy, Cost Plus Drugs, and Honeybee Health sometimes have stock that brick-and-mortar stores lack.

Discuss alternatives. Ask your doctor about ondansetron (Zofran) or promethazine as backup options. See: Alternatives to Compazine

Refill early. Do not wait until you run out of medication to start looking. Refill 5-7 days early within your insurance policy window.

Where to Monitor the Shortage

The most authoritative sources for drug shortage information are:

ASHP Drug Shortage Database (ashp.org) — real-time shortage listings, especially for injectables

FDA Drug Shortages Database (fda.gov/drugs/drug-shortages) — official FDA shortage listings

medfinder.com — real-time pharmacy-level availability search in your area